Search Results
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Christina Antza in
Google Scholar
PubMed
Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Samiul Mostafa in
Google Scholar
PubMed
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Krishnarajah Nirantharakumar in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Centre of Endocrinology Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Abd Tahrani in
Google Scholar
PubMed
) ( https://apps.who.int/gho/data/view.main.REGION2480A?lang=en Accessed (September) (2021)). Considering the health and economic consequences associated with obesity (type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), cancer, mortality), there
Search for other papers by Bernadette M Trojanowski in
Google Scholar
PubMed
Faculty of Pharmacy, King Khalid University, Abha, Saudi Arabia
Search for other papers by Heba H Salem in
Google Scholar
PubMed
Search for other papers by Heike Neubauer in
Google Scholar
PubMed
Search for other papers by Eric Simon in
Google Scholar
PubMed
Search for other papers by Martin Wagner in
Google Scholar
PubMed
Search for other papers by Rajkumar Dorajoo in
Google Scholar
PubMed
Imperial College London, London, UK
Search for other papers by Bernhard O Boehm in
Google Scholar
PubMed
Department of Biochemistry, University of São Paulo, São Paulo, Brazil
Search for other papers by Leticia Labriola in
Google Scholar
PubMed
Search for other papers by Thomas Wirth in
Google Scholar
PubMed
Search for other papers by Bernd Baumann in
Google Scholar
PubMed
Introduction Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous form of diabetes that is inherited in an autosomal-dominant pattern and in general, affected families have a history of diabetes over several generations
Search for other papers by T’ng Choong Kwok in
Google Scholar
PubMed
Search for other papers by Roland H Stimson in
Google Scholar
PubMed
( Cypess et al. 2009 , van Marken Lichtenbelt et al. 2009 ). More recent analysis of large datasets support the protective effects of 18 F-FDG uptake by human BAT at room temperature against developing type 2 diabetes mellitus (T2DM), hypertension and
Search for other papers by Ryan A Lafferty in
Google Scholar
PubMed
Search for other papers by Laura M McShane in
Google Scholar
PubMed
Search for other papers by Zara J Franklin in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Finbarr P M O’Harte in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction It has been well established that abnormal elevation in circulating glucagon leads to an increase in hepatic glucose production and glycogen metabolism that contribute to hyperglycaemia in diabetes ( Unger 1978 ). For this reason
Search for other papers by Alessandro Pocai in
Google Scholar
PubMed
Introduction As the prevalence of type 2 diabetes increases, there is a medical need for additional antihyperglycemic agents that offer improved efficacy in glycemic control and tolerability. Obesity is an important risk factor for a number of
Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tübingen, Tübingen, Germany
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, Eberhard-Karls University of Tübingen, Tübingen, Germany
Search for other papers by Gencer Sancar in
Google Scholar
PubMed
Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University of Tübingen, Tübingen, Germany
Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, Eberhard-Karls University of Tübingen, Tübingen, Germany
Search for other papers by Andreas L Birkenfeld in
Google Scholar
PubMed
fat can lead to a range of metabolic abnormalities and diseases, including dyslipidemia, metabolic dysfunction-associated steatotic liver disease (MASLD), β cell dysfunction, prediabetes, and type 2 diabetes (T2D). The common denominator of these
Search for other papers by A Edlund in
Google Scholar
PubMed
Search for other papers by M Barghouth in
Google Scholar
PubMed
Search for other papers by M Hühn in
Google Scholar
PubMed
Search for other papers by M Abels in
Google Scholar
PubMed
Search for other papers by J S E Esguerra in
Google Scholar
PubMed
Search for other papers by I G Mollet in
Google Scholar
PubMed
Search for other papers by E Svedin in
Google Scholar
PubMed
Search for other papers by A Wendt in
Google Scholar
PubMed
Search for other papers by E Renström in
Google Scholar
PubMed
Search for other papers by E Zhang in
Google Scholar
PubMed
Search for other papers by N Wierup in
Google Scholar
PubMed
Pediatric Pulmonology, Erasmus MC, Rotterdam, the Netherlands
Search for other papers by B J Scholte in
Google Scholar
PubMed
Search for other papers by M Flodström-Tullberg in
Google Scholar
PubMed
Search for other papers by L Eliasson in
Google Scholar
PubMed
reduced conductivity ( Wilke et al. 2011 ). Blood glucose abnormalities are common in CF and CF-related diabetes (CFRD) is a common secondary complication. Acquiring diabetes on the background of CF leads to an increased morbidity and mortality, and
Search for other papers by Alyce M Martin in
Google Scholar
PubMed
Search for other papers by Emily W Sun in
Google Scholar
PubMed
Nutrition and Metabolism, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
Search for other papers by Damien J Keating in
Google Scholar
PubMed
diseases such as type 2 diabetes (T2D) and markedly increased cardiovascular risk. Hepatic glucose production is the primary determinant of glucose homeostasis and is predominantly dictated by pancreatic insulin and glucagon. In addition, postprandial
Search for other papers by Hyo Youl Moon in
Google Scholar
PubMed
Search for other papers by Parkyong Song in
Google Scholar
PubMed
Search for other papers by Cheol Soo Choi in
Google Scholar
PubMed
Search for other papers by Sung Ho Ryu in
Google Scholar
PubMed
Search for other papers by Pann-Ghill Suh in
Google Scholar
PubMed
Introduction Excessive energy intake, including ingestion of a high-fat diet (HFD), and sedentary lifestyles cause hyperlipidemia, metabolic syndrome, and type II diabetes and are threatening to become a global epidemic ( Angulo 2007 , Lazo & Clark
Search for other papers by Neil Tanday in
Google Scholar
PubMed
Search for other papers by Aimee Coulter-Parkhill in
Google Scholar
PubMed
Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Search for other papers by Karthick Suruli in
Google Scholar
PubMed
Search for other papers by Vaibhav Dubey in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Nigel Irwin in
Google Scholar
PubMed
Introduction Epidemiological data suggest that males are at increased risk of developing type 2 diabetes (T2D) than females, but that this sex bias is absent with onset of the menopause ( Saeedi et al. 2020 ). Clearly, there is an